Randomized, Double Blind Evaluation of Sequential Administration of gp120 B/E (AIDSVAX B/E) (GSID) With 1-Year Boosting in HIV-uninfected Thai Adults
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 19 Jan 2018
At a glance
- Drugs HIV gp120 vaccine (Primary)
- Indications HIV-1 infections
- Focus Pharmacodynamics
- 11 Jan 2018 Planned End Date changed from 1 Feb 2018 to 1 Dec 2018.
- 11 Jan 2018 Planned primary completion date changed from 1 Dec 2017 to 1 Jun 2018.
- 12 Oct 2017 Status changed from recruiting to active, no longer recruiting.